VeriMomschizosaccharomyces pombe extract hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety flags were found for Schizosaccharomyces pombe extract. Literature (general PubMed records on S. pombe as a microbiological model) does not report reproductive or developmental toxicity from topical cosmetic use; cosmetic databases (CosIng/PubChem entries for yeast/ferment extracts) treat this as a topical/biotech-derived extract. Given lack of evidence for reproductive hazard and expected negligible dermal systemic absorption of large-biopolymer extracts, default scores are 0. Sources consulted: ECHA Annex VI (no listing), PubMed, CosIng, PubChem.
Pregnancy-safe products containing schizosaccharomyces pombe extract
Related ingredients
Frequently asked questions
- schizosaccharomyces pombe extract hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety flags were found for Schizosaccharomyces pombe extract. Literature (general PubMed records on S. pombe as a microbiological model) does not report reproductive or developmental toxicity from topical cosmetic use; cosmetic databases (CosIng/PubChem entries for yeast/ferment extracts) treat this as a topical/biotech-derived extract. Given lack of evidence for reproductive hazard and expected negligible dermal systemic absorption of large-biopolymer extracts, default scores are 0. Sources consulted: ECHA Annex VI (no listing), PubMed, CosIng, PubChem.
- schizosaccharomyces pombe extract emzirirken güvenli mi?
- No data indicating reproductive or lactation-related toxicity or systemic exposure that would affect breastfed infants. Yeast/ferment extracts are not identified as lactation hazards in available cosmetic/regulatory sources; therefore hazard and mechanism scores are 0 and dermal exposure is considered negligible for typical topical cosmetic use.
- schizosaccharomyces pombe extract bebek cildi için güvenli mi?
- No infant-specific reproductive or developmental toxicity data were identified. Mechanism/hazard remain 0. Exposure score increased to 1 for 0–3 yr skin because infant skin has higher permeability and surface-area-to-weight, and although large biochemical extracts have low dermal bioavailability, neonatal barrier immaturity makes a low but measurable exposure plausible.
- VeriMom schizosaccharomyces pombe extract nasıl puanlıyor?
- VeriMom schizosaccharomyces pombe extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte schizosaccharomyces pombe extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.